Medios to acquire NewCo Pharma for €125m.

Synopsis

Medios, a pharmaceutical company, agreed to acquire NewCo Pharma, a provider of patient-specific infusion solutions, for €125m. This enables Medios to significantly expand its business activities in the segment of patient-specific therapies throughout Germany.

Principals

target

Newco Pharma

bidder

Medios

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Market Context

kekst cnc

HQ - New York

pr advisors

bidder

1315

Deals

£ 1,108.76 B

Total Value